Artificial Intelligence (AI) In Biopharmaceuticals Global Market Report 2025

Description

Artificial intelligence (AI) applied in the biopharmaceutical sector involves the utilization of diverse AI techniques to analyze intricate biological data and enhance different aspects of drug discovery, development, and delivery within the pharmaceutical domain. This application of AI holds significant potential for transforming drug discovery, development, and delivery processes by expediting timelines, cutting costs, and enhancing the efficiency and efficacy of treatments.

The primary categories of offerings in artificial intelligence (AI) within the biopharmaceutical sector encompass hardware, software, and services. Hardware pertains to the tangible components of a computer system, including devices such as memory, disk drives, controllers, and specialized software such as database management systems. These offerings span various deployment models, encompassing both cloud-based and on-premises solutions. The technologies employed include machine learning, natural language processing, and deep learning, with applications spanning business processes, supply chains, drug discovery, medical imaging and diagnostics, and precision medicine. The end users of these AI solutions are diverse, ranging from manufacturers and contract research organizations to academic and government research institutes.

The artificial intelligence (AI) in biopharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) in biopharmaceuticals market statistics, including artificial intelligence (AI) in biopharmaceuticals industry global market size, regional shares, competitors with an artificial intelligence (AI) in biopharmaceuticals market share, detailed artificial intelligence (AI) in biopharmaceuticals market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) in biopharmaceuticals industry. This artificial intelligence (AI) in biopharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence (AI) in biopharmaceuticals market size has grown exponentially in recent years. It will grow from $1.59 billion in 2024 to $2.12 billion in 2025 at a compound annual growth rate (CAGR) of 33.1%. The growth in the historic period can be attributed to advancements in computational power, biomedical data explosion, precision medicine paradigm, regulatory support and guidance.

The artificial intelligence (AI) in biopharmaceuticals market size is expected to see exponential growth in the next few years. It will grow to $6.67 billion in 2029 at a compound annual growth rate (CAGR) of 33.2%. The growth in the forecast period can be attributed to advancements in computational biology, integration of multi-modal data, convergence of ai and life sciences, regulatory support and frameworks, ethical and fair ai principles. Major trends in the forecast period include integration of multi-omics data, AI-driven drug design and discovery, explainable AI and regulatory acceptance, technological advancements, regulatory developments, and emerging opportunities.

The increasing prevalence of chronic diseases is projected to drive the growth of the artificial intelligence (AI) in biopharmaceuticals market in the future. Chronic diseases are long-term conditions that typically progress slowly and can persist for years or even a lifetime. Factors contributing to these diseases include lifestyle choices, an aging population, genetic predispositions, and environmental influences. AI is increasingly utilized in biopharmaceuticals for managing chronic diseases as it can analyze vast amounts of diverse data, identify patterns, and personalize treatment strategies. For example, in November 2023, the Department of Health and Human Services, a US government agency, reported an 11 percent increase in newly documented chronic hepatitis B cases in 2022 compared to 2021. Consequently, the rising prevalence of chronic diseases is driving growth in the AI biopharmaceuticals market.

Key players in artificial intelligence (AI) in biopharmaceuticals are focused on developing innovative advancements such as target and lead identification suite AI-powered solutions to expedite drug discovery and enable precision medicine, thereby transforming life sciences organizations. These solutions for drug discovery and precision medicine encompass a variety of innovative approaches to developing new drugs and tailoring treatments to individual patients. For example, in May 2023, Google LLC, a US-based provider of cloud computing services, introduced two new AI-powered tools named target and lead identification suites. These tools are designed to assist researchers in predicting and understanding the structure of proteins, a fundamental aspect of drug development. Additionally, the suite facilitates the ingestion, storage, analysis, and sharing of large volumes of genomic data, crucial for precision medicine initiatives. Furthermore, these tools streamline the drug discovery process, reduce costs, and expedite the introduction of new treatments to market. By offering efficient data management, accurate predictions of protein structures, and advanced genomic analysis capabilities, these tools aim to revolutionize drug development processes and enhance patient outcomes.

In February 2023, ZS Associates, a management consulting and technology firm based in the United States, successfully acquired Trials.ai Inc. for an undisclosed sum. This strategic acquisition is geared towards elevating design processes within the pharmaceutical industry by harnessing artificial intelligence (AI). The goal is to optimize operational speed, enhance participant experiences, and accelerate the delivery of pharmaceutical therapies to the market. Trials.ai Inc., headquartered in the US, specializes in revolutionizing clinical trials through the application of artificial intelligence (AI) and machine learning (ML) technologies.

Major companies operating in the artificial intelligence (AI) in biopharmaceuticals market are Apple Inc., Google LLC, Microsoft Corporation, Tencent Holdings Limited, Amazon Web Services Inc., International Business Machines Corporation, Exscientia Limited, NVIDIA Corporation, Amgen Inc., DeepMind Technologies Limited, Schrodinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.

North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (ai) in biopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence (ai) in biopharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI) in biopharmaceuticals market consists of revenues earned by entities by services such as drug discovery, personalized medicine analytics, clinical trial optimization, healthcare decision support, and data integration and analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in biopharmaceuticals market also includes of sales of decision support System, predictive modeling tools, robotics, and automation systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI) In Biopharmaceuticals Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence (ai) in biopharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai) in biopharmaceuticals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The artificial intelligence (ai) in biopharmaceuticals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Offering: Hardware; Software; Services
2) By Deployment: Cloud; On-Premises
3) By Technology: Machine Learning; Natural Language Processing; Deep Learning; Other Technologies
4) By Application: Business Process And Supply Chain; Drug Discovery; Medical Imaging And Diagnostics; Precision Medicine
5) By End-Users: Manufacturers; Contract Research Organizations; Academic And Government Research Institutes
Subsegments:
1) By Hardware: High-Performance Computing Systems; AI-Enabled Laboratory Equipment; Data Storage Solutions
2) By Software: Drug Discovery Platforms; Clinical Trial Management Software; Predictive Analytics Tools; Natural Language Processing Solutions
3) By Services: Consulting Services; Implementation And Integration Services; Data Management And Analytics Services; Training And Support Services
Companies Mentioned: Apple Inc.; Google LLC; Microsoft Corporation; Tencent Holdings Limited; Amazon Web Services Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r27372

1. Executive Summary

2. Artificial Intelligence (AI) In Biopharmaceuticals Market Characteristics

3. Artificial Intelligence (AI) In Biopharmaceuticals Market Trends And Strategies

4. Artificial Intelligence (AI) In Biopharmaceuticals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Artificial Intelligence (AI) In Biopharmaceuticals Growth Analysis And Strategic Analysis Framework

5.1. Global Artificial Intelligence (AI) In Biopharmaceuticals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Artificial Intelligence (AI) In Biopharmaceuticals Market Growth Rate Analysis
5.4. Global Artificial Intelligence (AI) In Biopharmaceuticals Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Artificial Intelligence (AI) In Biopharmaceuticals Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Artificial Intelligence (AI) In Biopharmaceuticals Total Addressable Market (TAM)

6. Artificial Intelligence (AI) In Biopharmaceuticals Market Segmentation

6.1. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hardware
Software
Services
6.2. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cloud
On-Premises
6.3. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Machine Learning
Natural Language Processing
Deep Learning
Other Technologies
6.4. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Business Process And Supply Chain
Drug Discovery
Medical Imaging And Diagnostics
Precision Medicine
6.5. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Manufacturers
Contract Research Organizations
Academic And Government Research Institutes
6.6. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
High-Performance Computing Systems
AI-Enabled Laboratory Equipment
Data Storage Solutions
6.7. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug Discovery Platforms
Clinical Trial Management Software
Predictive Analytics Tools
Natural Language Processing Solutions
6.8. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Consulting Services
Implementation And Integration Services
Data Management And Analytics Services
Training And Support Services

7. Artificial Intelligence (AI) In Biopharmaceuticals Market Regional And Country Analysis

7.1. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence (AI) In Biopharmaceuticals Market

8.1. Asia-Pacific Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence (AI) In Biopharmaceuticals Market

9.1. China Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
9.2. China Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence (AI) In Biopharmaceuticals Market

10.1. India Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence (AI) In Biopharmaceuticals Market

11.1. Japan Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
11.2. Japan Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence (AI) In Biopharmaceuticals Market

12.1. Australia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence (AI) In Biopharmaceuticals Market

13.1. Indonesia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence (AI) In Biopharmaceuticals Market

14.1. South Korea Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
14.2. South Korea Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence (AI) In Biopharmaceuticals Market

15.1. Western Europe Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
15.2. Western Europe Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence (AI) In Biopharmaceuticals Market

16.1. UK Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence (AI) In Biopharmaceuticals Market

17.1. Germany Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence (AI) In Biopharmaceuticals Market

18.1. France Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence (AI) In Biopharmaceuticals Market

19.1. Italy Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence (AI) In Biopharmaceuticals Market

20.1. Spain Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence (AI) In Biopharmaceuticals Market

21.1. Eastern Europe Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
21.2. Eastern Europe Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence (AI) In Biopharmaceuticals Market

22.1. Russia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence (AI) In Biopharmaceuticals Market

23.1. North America Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
23.2. North America Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence (AI) In Biopharmaceuticals Market

24.1. USA Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
24.2. USA Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence (AI) In Biopharmaceuticals Market

25.1. Canada Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
25.2. Canada Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence (AI) In Biopharmaceuticals Market

26.1. South America Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
26.2. South America Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence (AI) In Biopharmaceuticals Market

27.1. Brazil Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence (AI) In Biopharmaceuticals Market

28.1. Middle East Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
28.2. Middle East Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence (AI) In Biopharmaceuticals Market

29.1. Africa Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
29.2. Africa Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence (AI) In Biopharmaceuticals Market Competitive Landscape And Company Profiles

30.1. Artificial Intelligence (AI) In Biopharmaceuticals Market Competitive Landscape
30.2. Artificial Intelligence (AI) In Biopharmaceuticals Market Company Profiles
- 30.2.1. Apple Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Google LLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Tencent Holdings Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Amazon Web Services Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence (AI) In Biopharmaceuticals Market Other Major And Innovative Companies

31.1. International Business Machines Corporation
31.2. Exscientia Limited
31.3. NVIDIA Corporation
31.4. Amgen Inc.
31.5. DeepMind Technologies Limited
31.6. Schrodinger Inc.
31.7. XtalPi Inc.
31.8. ConcertAI Inc.
31.9. Insilico Medicine Inc.
31.10. Recursion Pharmaceuticals
31.11. BenevolentAI
31.12. BioXcel Therapeutics
31.13. Atomwise Inc.
31.14. BioAge Labs Inc.
31.15. GNS Healthcare

32. Global Artificial Intelligence (AI) In Biopharmaceuticals Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence (AI) In Biopharmaceuticals Market

34. Recent Developments In The Artificial Intelligence (AI) In Biopharmaceuticals Market

35. Artificial Intelligence (AI) In Biopharmaceuticals Market High Potential Countries, Segments and Strategies

35.1 Artificial Intelligence (AI) In Biopharmaceuticals Market In 2029 - Countries Offering Most New Opportunities
35.2 Artificial Intelligence (AI) In Biopharmaceuticals Market In 2029 - Segments Offering Most New Opportunities
35.3 Artificial Intelligence (AI) In Biopharmaceuticals Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer